Structurally modified fatty acids: Clinical potential as tracers of metabolism
- 1 August 1986
- journal article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 12 (S1) , S45-S48
- https://doi.org/10.1007/bf00258104
Abstract
Recently 15-p-iodophenyl-β-methyl-pentadecanoic acid (BMPPA) was proposed for use in myocardial scintigraphy, as a possible probe of metabolic processes other than β-oxidation. In 19 patients (CAD/15, St.p. Mi/7; control 4) myocardial scintigraphy was carried out after i.v. I-123-BMPPA (2–4 mCi). Data were collected (LAO 45°/14; anterior/5) for 100 min in the fasted patients. Organ to background (BG) ratios were calculated for the heart (H) and liver (L), and the elimination (E) behaviour was analyzed from BG (vena cava region) corrected time activity curves. In 10 patients plasma and urine were examined. By CHCl3/MeOH extraction of plasma samples (90 min after injection), both in water and in organic medium soluble catabolites were found. TLC fractionation showed that those were co-migrating, compared to standards, with bencoic acid, BMPPA and trigylcerides. In the urine (0–2 h after injection, 4.1% dose) hippuric acid was found. The mean t-max of BMPPA occurred at 15 min in the heart and at 9 min in the liver (P<0.01), with H/BG and L/BG ratios of 1.8 and 2.1, respectively. The elimination of BMPPA was slower from the heart than from the liver (P<0.01). It was biexponential from the liver in all cases ( \(\bar x\) : t/2 I, 11.4 min; t/2 II, 92 min; t/2 I uncor., 38 min) with the size of phase I smaller than that of phase II ( \(\bar x\) : I/II, 0.57). From the heart BMPPA turnover was biexponential in 11 patients ( \(\bar x\) : t/2 I, 13.8 min; t/2 II, 187 min; t/2 I uncor., 65 min; I/II, 0.34), but monoexponential in 8 ( \(\bar x\) : t/2, 218 min). In 13 diseased regions (MI/7) BMPPA uptake was reduced, and the E behaviour was mostly abnormal as compared to the respective undiseased region. We conclude that BMPPA is a useful agent for myocardial scintigraphy. Its longer retention time in the heart compared to unbranched radioiodinated fatty acids may facilitate SPECT studies. E behaviour and plasma analysis indicate that BMPPA is metabolically broken down. Yet, the complexity of the supposed mechanism may impede curve interpretation in terms of specific metabolic pathways.
Keywords
This publication has 21 references indexed in Scilit:
- Regional Myocardial Substrate Uptake in Hypertensive Rats: a Quantitative Autoradiographic MeasurementScience, 1985
- ω-Halofatty acids: A probe for mitochondrial membrane integrityEuropean Journal of Nuclear Medicine and Molecular Imaging, 1984
- New myocardial imaging agents: synthesis of 15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid by decomposition of a 3,3-(1,5-pentanediyl)triazene precursorThe Journal of Organic Chemistry, 1984
- The use of 123I-labeled heptadecanoic acid (HDA) as metabolic tracer: Preliminary reportEuropean Journal of Nuclear Medicine and Molecular Imaging, 1984
- OMEGA-HALOFATTY ACIDS - A PROBE FOR MITOCHONDRIAL-MEMBRANE INTEGRITY - INVITRO INVESTIGATIONS IN NORMAL AND ISCHEMIC MYOCARDIUM1984
- Dynamic myocardial scintigraphy with 123I-labeled free fatty acids in patients with myocardial infarctionEuropean Journal of Nuclear Medicine and Molecular Imaging, 1981
- Metabolic myocardial imaging with 123I-labeled heptadecanoic acid in patients with angina pectorisEuropean Journal of Nuclear Medicine and Molecular Imaging, 1981
- Non-invasive analysis of metabolic reactions in body tissues, the case of myocardial fatty acidsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1981
- EFFECTS OF CHAIN-LENGTH AND TELLURIUM POSITION ON THE MYOCARDIAL UPTAKE OF TE-123M FATTY-ACIDS1981
- Biochemical concept and synthesis of a radioiodinated phenylfatty acid for in vivo metabolic studies of the myocardiumEuropean Journal of Nuclear Medicine and Molecular Imaging, 1980